Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04972162 · ClinicalTrials.gov registry record · NA
Fitting Strategy Study
A NA study of Hearing Loss, Sensorineural, sponsored by Wsaud A/S.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT04972162: Completed NA study of Hearing Loss, Sensorineural, sponsored by Wsaud A/S.
NCT04972162 is a NA study of Hearing Loss, Sensorineural that has completed, run by Wsaud A/S. The registered enrollment target is 28 participants, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04972162, a NA study of Hearing Loss, Sensorineural, has completed, sponsored by Wsaud A/S.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
To be conducted with adult participants with mild-to-moderate hearing loss to validate the effectiveness of the Web App fitting strategy. Validation measures participant's perceived hearing aid benefit when using the Web App fitted hearing aids and when using standard-of-care fitted hearing aids.
Primary Outcome
The APHAB consists of 24 questions across 4 subscales: Ease of Communication (EC), Background Noise (BN), Reverberation (RV), and Aversiveness (AV), assessing hearing difficulties in daily situations reported as percentage of problems (0-100%, 100% = highest number of problems). It evaluates hearing aid (HA) benefit by subtracting the reported % of problems with HA from without HA, yielding scores from 0 (no benefit) to 100 (maximum benefit) in each subscale. The study focuses on the communicati
Conditions Studied
Interventions
- DEVICE Web App Strategy Fitting
- DEVICE Standard-of-care Fitting
Study Locations (1)
South Dakota
- University of South Dakota, USD Speech and Hearing Clinic - Vermillion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-07-26 |
| Est. Completion | 2021-11-12 |
| Phase | NA |
What the finished NCT04972162 record still lists
NCT04972162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 2 interventions - of which Web App Strategy Fitting is the first listed.
NCT04972162 reports a single indexed study location in South Dakota.
Frequently Asked Questions
What is clinical trial NCT04972162 about?
NCT04972162 is a clinical study titled "Fitting Strategy Study". To be conducted with adult participants with mild-to-moderate hearing loss to validate the effectiveness of the Web App fitting strategy. Validation measures participant's perceived hearing aid benefit when using the Web App fitted hearing aids and when using standard-of-care fitted hearing aids.
What is the current status of trial NCT04972162?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2021-07-26. Estimated completion is 2021-11-12.
What conditions does trial NCT04972162 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural.
What interventions are being tested in trial NCT04972162?
The interventions under investigation include: Web App Strategy Fitting (DEVICE), Standard-of-care Fitting (DEVICE).
Who is sponsoring clinical trial NCT04972162?
This trial is sponsored by Wsaud A/S, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04972162 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04972162's enrollment target sits among peer trials
28 16th of 20 higher than 5 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Reading Outcomes in Children With Vestibular Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI